TAF
HZNP

Tredje AP-fonden’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Tredje AP-fonden’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-35,899
Closed -$4.15M – 556
2023
Q3 		$4.15M Sell
35,899
-3,273
-8% -$352K 0.06% 202
2023
Q2 		$4.03M Sell
39,172
-6,919
-15% -$730K 0.06% 228
2023
Q1 		$5.03M Hold
46,091
– – 0.08% 178
2022
Q4 		$5.25M Hold
46,091
– – 0.09% 170
2022
Q3 		$2.85M Buy
+46,091
New +$3.22M 0.06% 250

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Tredje AP-fonden's HZNP Position: Q4 2023 in Review

Tredje AP-fonden sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 35,899 shares — an estimated $4.15M sold.

Tredje AP-fonden first reported a position in HZNP in Q3 2022 and held it in 5 quarters. The position peaked at $5.25M in Q4 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Tredje AP-fonden reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Tredje AP-fonden sold 35,899 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $4.15M.
  • Tredje AP-fonden first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2022 and held it in 5 quarters.
  • Tredje AP-fonden's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $5.25M in Q4 2022.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Tredje AP-fonden's 13F filing for Q4 2023, filed 12 Feb 2024.